Category:ALK inhibitors

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 13:57, 22 January 2021 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was Crizotinib (Xalkori).

Pages in category "ALK inhibitors"

The following 9 pages are in this category, out of 9 total.

A

Alectinib (Alecensa)

B

Brigatinib (Alunbrig)

C

E

G

Gilteritinib (Xospata)

L

Lorlatinib (Lorbrena)

R

Repotrectinib (Augtyro)

Retrieved from "https://hemonc.org/w/index.php?title=Category:ALK_inhibitors&oldid=46977"

Tyrosine kinase inhibitors